<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03507504</url>
  </required_header>
  <id_info>
    <org_study_id>H2020 Proposal, number: 779237</org_study_id>
    <nct_id>NCT03507504</nct_id>
  </id_info>
  <brief_title>REspectful CAring for the AGitated Elderly</brief_title>
  <acronym>RECAGE</acronym>
  <official_title>REspectful CAring for the AGitated Elderly. How to Best Meet the Needs of People With Dementia With Severe Behavioural Disturbances. Toward a Respectful and Cost-effective Model</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione Europea di Ricerca Biomedica Ferb Onlus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mediolanum Cardio Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fondazione Europea di Ricerca Biomedica Ferb Onlus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The treatment of Behavioural and Psychological Symptoms of Dementia (BPSD) continue to raise
      difficult problems. Both the pharmacologic and non-pharmacologic therapies often fail to
      achieve the expected results. The aim of this study is to assess the short- and long-term
      efficacy of an intervention, the Special Care Unit for patients with BPSD (SCU-B), already
      implemented in some countries but not validated so far, as well as its cost-effectiveness
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Two cohorts of 250 patients each will be recruited by six clinical centres endowed with a
      SCU-B (one cohort) and six centres lacking this structure. The follow-up will last 3 years,
      during which patients will be visited every 6 months and submitted to a battery exploring the
      severity of the BPSD and the quality of life. All adverse events will be registered, as well
      as some anticipated occurrences (admissions to the general hospital for intercurrent
      diseases, admissions to a SCU-B pertaining to the clinical participating centre and, if any,
      admissions to a SCU-B not pertaining to the Consortium member, nursing home placement).

      At the same time the quality of life of the primary caregivers will be measured, as well as
      their attitude toward dementia.

      A cost-effectiveness analysis will be performed comparing the cohorts. Finally the time to
      the nursing home placement will be recorded and compared between the two cohorts
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>change of BPSD</measure>
    <time_frame>baseline, 6, 12, 18, 24, 30, 36 months</time_frame>
    <description>Neuropsychiatric Inventory (NPI), range 0-144</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>quality of life of patients</measure>
    <time_frame>baseline, 6, 12,18, 24, 30, 36 months</time_frame>
    <description>Quality of Life Alzheimer's Disease (QoL-AD), range 0-52</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life of caregivers</measure>
    <time_frame>baseline, 6, 12, 18, 24, 30, 36 months</time_frame>
    <description>Caregiver Burden Inventory (CBI), range 0-96</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cost-effectiveness of SCU-B</measure>
    <time_frame>baseline, 6, 12, 18, 24, 30, 36 months</time_frame>
    <description>Resource Utilisation in Dementia (RUD)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>delayed institutionalisation</measure>
    <time_frame>until 3 years</time_frame>
    <description>Time to nursing home placement</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Dementia</condition>
  <arm_group>
    <arm_group_label>care pathway with SCU-B</arm_group_label>
    <description>250 patients with dementia and behavioural and psychological symptoms of dementia (BPSD) followed up by six clinical centres with a Special Care Unit for BPSD (SCU-B)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>care pathway without SCU-B</arm_group_label>
    <description>250 patients with dementia and BPSD followed up by six clinical centres without SCU-B</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SCU-B</intervention_name>
    <description>SCU-B is &quot;a residential medical structure lying outside of a nursing home, in a general hospital or elsewhere, e.g. in a private hospital, where patients with BPSD are temporarily admitted when their behavioural disturbances are not amenable to control at home&quot;.</description>
    <arm_group_label>care pathway with SCU-B</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The population studied is made by the outpatients with dementia referred to the memory
        clinics of 12 clinical centres located in seven European countries (Italy, Germany, France,
        Belgium, Greece, Switzerland, Norway)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of primary dementia (DSM IV)

          -  MMSE score ≤ 24

          -  NPI global score ≥ 32/144

          -  a caregiver (informal/family member or formal caregiver) who commits her/himself to
             accompany the patient along the three-year course of the study

          -  living at home (nursing home residents are excluded).

        Exclusion Criteria:

          -  presence of uncontrolled medical disease potentially contributing to the cognitive
             decline and BPSD

          -  concomitant psychiatric disorders or chronic alcoholism

          -  concomitant diseases severe enough to reduce life expectancy &lt; 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlo A Defanti, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Fondazione Europea di Ricerca Biomedica</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carla Finocchiaro, Ph.D.</last_name>
    <phone>+390231083323</phone>
    <email>carla.finocchiaro@cf-c.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sara Fascendini, M.D.</last_name>
    <phone>+390353065206</phone>
    <email>recage@ferbonlus.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire St Pierre</name>
      <address>
        <city>Bruxelles</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean P Praet, M.D.</last_name>
      <phone>+3225354118</phone>
      <email>jean-philippe_praet@stpierre-bru.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Assistance Publique - Hopitaux de Paris</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jacques Hugon, M.D.</last_name>
      <phone>+33149958484</phone>
      <email>jacques.hugon@inserm.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zentralinstitut für Seelische Gesundheit</name>
      <address>
        <city>Mannheim</city>
        <state>Baden-Wurttenberg</state>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lutz Froelich, M.D.</last_name>
      <phone>+4962117033001</phone>
      <email>lutz.froelich@zi-mannheim.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Oliver Peters, M.D.</last_name>
      <phone>+4930450517942</phone>
      <email>oliver.peters@charite.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aristotelio Panepistimio Thessalonikis (Greece)</name>
      <address>
        <city>Thessaloníki</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Magda Tsolaki, M.D.</last_name>
      <email>tsolakim1@gmail.com</email>
    </contact>
    <contact_backup>
      <phone>+302310234239</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Cliniche Gavazzeni SpA</name>
      <address>
        <city>Bergamo</city>
        <state>BG</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paola Merlo, M.D.</last_name>
      <phone>+390354204668</phone>
      <email>paola.merlo@gavazzeni.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fondazione Europea di Ricerca Biomedica</name>
      <address>
        <city>Gazzaniga</city>
        <state>BG</state>
        <zip>24020</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sara Fascendini, M.D.</last_name>
      <phone>+390353065206</phone>
      <email>recage@ferbonlus.com</email>
    </contact>
    <contact_backup>
      <last_name>Federica Barocco, M.D.</last_name>
      <phone>+390353065206</phone>
      <email>federica.barocco@ferbonlus.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Azienda Socio Sanitaria Territoriale di Mantova</name>
      <address>
        <city>Mantova</city>
        <state>MN</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alfonso Ciccone, M.D.</last_name>
      <phone>+390376201543</phone>
      <email>alfonso.ciccone@asst-mantova.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Unità Sanitaria Locale di Modena</name>
      <address>
        <city>Modena</city>
        <state>MO</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrea Fabbo, M.D.</last_name>
      <phone>+39059435201</phone>
      <email>a.fabbo@ausl.mo.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Università degli Studi di Perugia</name>
      <address>
        <city>Perugia</city>
        <state>PG</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patrizia Mecocci, M.D.</last_name>
      <phone>+390755783270</phone>
      <email>patrizia.mecocci@unipg.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sykehuset Innlandet</name>
      <address>
        <city>Ottestad</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sverre Bergh, M.D.</last_name>
      <phone>+4745679393</phone>
      <email>sverre.bergh@sykehuset-innlandet.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Université de Genève</name>
      <address>
        <city>Genève</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Giovanni B Frisoni, M.D.</last_name>
      <phone>+410223055762</phone>
      <email>giovanni.frisoni@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Italy</country>
    <country>Norway</country>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Koskas P, Belqadi S, Mazouzi S, Daraux J, Drunat O. [Behavioral and psychological symptoms of dementia in a pilot psychogeriatric unit: management and outcomes]. Rev Neurol (Paris). 2011 Mar;167(3):254-9. doi: 10.1016/j.neurol.2010.07.030. Epub 2010 Oct 14. French.</citation>
    <PMID>20947112</PMID>
  </reference>
  <reference>
    <citation>Delphin-Combe F, Roubaud C, Martin-Gaujard G, Fortin ME, Rouch I, Krolak-Salmon P. [Effectiveness of a cognitive-behavioral unit on behavioral and psychological symptoms of dementia]. Rev Neurol (Paris). 2013 Jun-Jul;169(6-7):490-4. doi: 10.1016/j.neurol.2012.10.017. Epub 2013 Mar 21. French.</citation>
    <PMID>23523558</PMID>
  </reference>
  <reference>
    <citation>Bianchetti A, Benvenuti P, Ghisla KM, Frisoni GB, Trabucchi M. An Italian model of dementia special care unit: results of a pilot study. Alzheimer Dis Assoc Disord. 1997 Mar;11(1):53-6.</citation>
    <PMID>9071445</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 9, 2018</study_first_submitted>
  <study_first_submitted_qc>April 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2018</study_first_posted>
  <last_update_submitted>April 15, 2018</last_update_submitted>
  <last_update_submitted_qc>April 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fondazione Europea di Ricerca Biomedica Ferb Onlus</investigator_affiliation>
    <investigator_full_name>Carlo Alberto Defanti</investigator_full_name>
    <investigator_title>Study Coordinator</investigator_title>
  </responsible_party>
  <keyword>psychiatric aspects</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified participant data both for primary and secondary outcome measures will be made available</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

